Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Gastroparesis-Pipeline Insights, 2015 - A DelveInsight’s ReportDelveInsight, the leading market research and consulting company has added a new report “Gastroparesis-Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight.
By: DelveInsight Business Research • The report gives information of around 15 pipeline drugs with 10+ companies involved in drug development. There are 2 drugs in Phase III, 5 in Phase II, 5 inactive and 2 discontinued drugs. • Metoclopramide Hydrochloride developed by Evoke Pharma and Etx 101 developed by ETX Pharma, Inc are under Phase III clinical trials. • R& • Stages of development of pipeline molecules. • Therapeutic assessments by molecule types, route of administration, monotherapy and combination products. • Information related to collaborations, in-licensing and out-licensing deals. DelveInsight’ DelveInsight is offering the Report at a price of USD 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License. For more information on Pipeline Insight Reports, email atinfo@delveInsight.com Contact Us: DelveInsight Business Research New Delhi-110075, India Phone: +91-11-45689769, +91 9650213330 Website: http://delveinsight.com About Us DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making, identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients. End
Page Updated Last on: Oct 12, 2015
|
|